Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Hypofractionated Stereotactic Boost in Prostate Cancer [Phase 2]
This is a Phase 2 clinical trial update on hypofractionated stereotactic boost for prostate cancer, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer [Phase 1, Phase 2]
A terminated Phase 1/2 trial assessed neoadjuvant Lu-PSMA radioligand therapy in combination with ipilimumab for men with very high-risk pro…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer [EARLY_Phase 1]
An early-phase trial update reports the biodistribution of the 99mTc-PSMA-I&S imaging agent in patients with prostate cancer. Recruitment fo…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)
A clinical trial investigating detection of prostate cancer using Voided Urine (Prostate VPAC) is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial [Phase 2]
A Phase 2 clinical trial (RE-LuPSMA, NCT06288113) is evaluating re-treatment with Lutetium-177 PSMA-617 for metastatic castration-resistant …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating BMS986365 in combination with degarelix for prostate cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial [Phase 2]
A Phase 2 clinical trial (EnrichPSMA) is evaluating relugolix as androgen deprivation therapy to improve PSMA PET/CT imaging in high-risk or…
-
CLINICAL_TRIALS other · 2026-03-13Clinical Trial Update: Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners [Phase 2]
A Phase 2 clinical trial update notes termination of a study evaluating a neuroscience-based technique in colorectal cancer, bladder cancer,…
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy [EARLY_Phase 1]
This report summarizes results from a Phase 1 trial of rituximab given as neoadjuvant therapy before radical prostatectomy in men with prost…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) [Phase 1, Phase 2]
PMV Pharmaceuticals is evaluating PC14586 in a Phase 1/2 trial for advanced solid tumors harboring the TP53 Y220C mutation. The study is cur…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial [NA]
The REMOVE trial update describes a clinical study examining whether structured exercise can exert tumor-suppressive effects in Black men wi…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy. [NA]
This clinical trial is evaluating salvage stereotactic body radiotherapy to the prostate bed for biochemical recurrence following radical pr…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer [Phase 1]
A Phase I study of GLR2037 in advanced prostate cancer has been announced. The trial is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating Teverelix DP, a GnRH antagonist, for pharmacokinetics, pharmacodynamics, efficacy and safety in adv…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Leveraging EA8191 to Assess AI-Augmented EHR Abstraction
A University of Pennsylvania clinical trial update describes evaluating the compound EA8191 for AI-assisted electronic health record abstrac…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis [NA]
This clinical trial update reports a study comparing two diagnostic approaches, TB+PB and TB+6SB, for diagnosing prostate cancer and notes t…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: PROCARE - PROstate Cancer Real World Evidence Registry
PROCARE is a prostate cancer real-world evidence registry that is currently recruiting participants, collecting data across multiple disease…
-
CLINICAL_TRIALS other · 2026-03-12Clinical Trial Update: CARE Tool Study Aim 3 [NA]
Clinical trial update for CARE Tool Study Aim 3; the trial is not yet recruiting, and listed cancer indications include gynecologic cancer, …
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Effects of Music Therapy on Anxiety and Distress Levels During Radionuclide Treatment in Prostate Cancer Patients [NA]
A completed clinical trial evaluating the effects of music therapy on anxiety and distress during radionuclide treatment in prostate cancer …
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy [Phase 1, Phase 2]
Clinical trial evaluating safety and efficacy of HDR prostate brachytherapy doses of 21 Gy, 23 Gy, and 25 Gy in Phase 1/2. The study is curr…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC [Phase 1]
Phase 1 trial evaluating pTVG-HP in combination with nivolumab and targeted ablation for resistant lesions in non-castrate recurrent oligome…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Terbium 161 PSMA in Lutetium-177 PSMA Naive Patients [Phase 2]
Phase 2 trial evaluating Terbium-161 labeled PSMA in Lutetium-177 PSMA-naive prostate cancer patients; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer [Phase 2]
A Phase 2 clinical trial from Cedars-Sinai Medical Center is evaluating intensive cholesterol-lowering together with CD8+ T cell–related str…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial [NA]
This is a ClinicalTrials.gov registration for the FIERCE trial evaluating multi-component exercise to address frailty and sarcopenia in meta…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Transperineal Micro-ultrasound for the Detection of Prostate Cancer During Biopsy [NA]
A Roswell Park Cancer Institute trial is evaluating transperineal micro-ultrasound to detect prostate cancer during biopsy, and it is not ye…